|
1
|
Hagymasi K and Tulassay Z: Risk factors
for esophageal cancer, and possible genetic background. Orv Hetil.
150:407–413. 2009.(In Hungarian). PubMed/NCBI
|
|
2
|
Tsuyama S, Kohsaka S, Hayashi T, Suehara
Y, Hashimoto T, Kajiyama Y, Tsurumaru M, Ueno T, Mano H, Yao T and
Saito T: Comprehensive clinicopathological and molecular analysis
of primary malignant melanoma of the oesophagus. Histopathology.
78:240–251. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen R, Zheng RS, Zhang SW, Zeng HM, Wang
SM, Sun KX, Gu XY, Wei WW and He J: Analysis of incidence and
mortality of esophageal cancer in China, 2015. Zhonghua Yu Fang Yi
Xue Za Zhi. 53:1094–1097. 2019.(In Chinese). PubMed/NCBI
|
|
4
|
Cools-Lartigue J, Spicer J and Ferri LE:
Current status of management of malignant disease: Current
management of esophageal cancer. J Gastrointest Surg. 19:964–972.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van Laarhoven HW: Is chemotherapy for
advanced or metastatic oesophageal squamous cell carcinoma no
longer needed? Lancet Oncol. 21:743–745. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fatehi Hassanabad A, Chehade R, Breadner D
and Raphael J: Esophageal carcinoma: Towards targeted therapies.
Cell Oncol (Dordr). 43:195–209. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Seroussi E, Pan HQ, Kedra D, Roe BA and
Dumanski JP: Characterization of the human NIPSNAP1 gene from
22q12: A member of a novel gene family. Gene. 212:13–20. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang XY, Smith DI, Liu W and James CD:
GBAS, a novel gene encoding a protein with tyrosine phosphorylation
sites and a transmembrane domain, is co-amplified with EGFR.
Genomics. 49:448–451. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abudu YP, Pankiv S, Mathai BJ, Lamark T,
Johansen T and Simonsen A: NIPSNAP1 and NIPSNAP2 act as ‘eat me’
signals to allow sustained recruitment of autophagy receptors
during mitophagy. Autophagy. 15:1845–1847. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abudu YP, Pankiv S, Mathai BJ, Håkon
Lystad A, Bindesbøll C, Brenne HB, Yoke Wui Ng M, Thiede B,
Yamamoto A, Mutugi Nthiga T, et al: NIPSNAP1 and NIPSNAP2 Act as
‘Eat Me’ signals for mitophagy. Dev Cell. 49:509–525.e12. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hong MJ, Lee SY, Choi JE, Kang HG, Do SK,
Lee JH, Yoo SS, Lee EB, Seok Y, Cho S, et al: Intronic variant of
EGFR is associated with GBAS expression and survival outcome of
early-stage non-small cell lung cancer. Thorac Cancer. 9:916–923.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang X, Bai Y, Han Y, Meng J and Liu H:
Downregulation of GBAS regulates oral squamous cell carcinoma
proliferation and apoptosis via the p53 signaling pathway. Onco
Targets Ther. 12:3729–3742. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L and Ouyang L: Effects of EIF3B gene
downregulation on apoptosis and proliferation of human ovarian
cancer SKOV3 and HO-8910 cells. Biomed Pharmacother. 109:831–837.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Green DR: Cancer and apoptosis: Who is
built to last? Cancer Cell. 31:2–4. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kaczanowski S: Apoptosis: Its origin,
history, maintenance and the medical implications for cancer and
aging. Phys Biol. 13:0310012016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng LS, Davis RC, Raffel LJ, Xiang AH,
Wang N, Quiñones M, Wen PZ, Toscano E, Diaz J, Pressman S, et al:
Coincident linkage of fasting plasma insulin and blood pressure to
chromosome 7q in hypertensive hispanic families. Circulation.
104:1255–1260. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Li S and Liu H: Co-delivery of
chitosan nanoparticles of 5-aminolevulinic acid and shGBAS for
improving photodynamic therapy efficacy in oral squamous cell
carcinomas. Photodiagnosis Photodyn Ther. 34:1022182021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gregory CD, Ford CA and Voss JJ:
Microenvironmental effects of cell death in malignant disease. Adv
Exp Med Biol. 930:51–88. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pachl J, Duska F, Waldauf P, Fric M, Fanta
J and Zdarsky E: Apoptosis as an early event in the development of
multiple organ failure? Physiol Res. 54:697–699. 2005.PubMed/NCBI
|
|
21
|
Malhotra A, Shibata Y, Hall IM and Dutta
A: Chromosomal structural variations during progression of a
prostate epithelial cell line to a malignant metastatic state
inactivate the NF2, NIPSNAP1, UGT2B17, and LPIN2 genes. Cancer Biol
Ther. 14:840–852. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schoeber JP, Topala CN, Lee KP, Lambers
TT, Ricard G, van der Kemp AW, Huynen MA, Hoenderop JG and Bindels
RJ: Identification of Nipsnap1 as a novel auxiliary protein
inhibiting TRPV6 activity. Pflugers Arch. 457:91–101. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Okuda-Ashitaka E, Minami T, Tsubouchi S,
Kiyonari H, Iwamatsu A, Noda T, Handa H and Ito S: Identification
of NIPSNAP1 as a nocistatin-interacting protein involving pain
transmission. J Biol Chem. 287:10403–10413. 2012. View Article : Google Scholar : PubMed/NCBI
|
